Search - Université de Rennes Access content directly

Filter your results

9 Results
authFullName_s : Xavier Thomas

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

Yves Bertrand , André Baruchel , Xavier Thomas , Nicolas Blin , Emmanuelle Tavernier et al.
Blood, 2015, 126 (23), pp.3734
Journal articles hal-01290438v1

Abstract CT113: A phase III, multicenter, randomized study evaluating the efficacy and safety and efficacy of erythrocyte encapsulated l-asparaginase (Ery001) versus native l-asparaginase (L-asp) in combination with COOPRALL regimen in patients with first relapse of acut

Yves Bertrand , André Baruchel , Xavier Thomas , Nicolas Blin , Emmanuelle Tavernier et al.
Cancer Research, 2015, 75 (15 Supplement), pp.CT113--CT113. ⟨10.1158/1538-7445.AM2015-CT113⟩
Journal articles hal-01300807v1

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Lionel Adès , Xavier Thomas , Agnes Cuerci-Bres , Raffoux Emmanuel , Olivier Spertini et al.
Blood, 2015, 126 (23), pp.451
Journal articles hal-01300812v1

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

Raouf Ben Abdelali , Vahid Asnafi , Thibaut Leguay , Nicolas Boissel , Agnès Buzyn et al.
Blood, 2011, 118 (19), pp.5099-107. ⟨10.1182/blood-2011-02-334219⟩
Journal articles hal-00777203v1

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.

Mathilde Hunault-Berger , Thibaut Leguay , Xavier Thomas , Ollivier Legrand , Françoise Huguet et al.
Haematologica, 2011, 96 (2), pp.245-52. ⟨10.3324/haematol.2010.027862⟩
Journal articles hal-00821138v1

Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

André Baruchel , Yves Bertrand , Xavier Thomas , Nicolas Blin , Emmanuelle Tavernier et al.
Blood, 2015, 126 (23), pp.3723
Journal articles hal-01290425v1

Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7)

Xavier Thomas , Yves Bertrand , André Baruchel , Nicolas Blin , Emmanuelle Tavernier et al.
Blood, 2015, 126 (23), pp.2492
Journal articles hal-01290427v1
Image document

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience

Marie-Anne Couturier , Françoise Huguet , Patrice Chevallier , Felipe Suarez , Xavier Thomas et al.
American Journal of Hematology, 2015, 90 (11), pp.986--991. ⟨10.1002/ajh.24130⟩
Journal articles hal-01231425v1